| Name | 1-[5-[3-(1-adamantyl)-4-methoxyphenyl]-2-methoxyphenyl]adamantane |
|---|---|
| Synonyms |
4,4'-Dimethoxy-3,3'-di(adamant-1-yl)biphenyl
1,1'-(4,4'-dimethoxy-[1,1'-biphenyl]-3,3'-diyl)bis(adamantane) Tricyclo[3.3.1.13,7]decane, 1,1'-(4,4'-dimethoxy[1,1'-biphenyl]-3,3'-diyl)bis 3,3'-diadamantyl-4,4'-dimethoxybiphenyl 4,4′-Dimethoxy-3,3′-di(adamant-1-yl)biphenyl 1,1'-[4,4'Bis(methoxy)biphenyl-3,3' Adapalene Related Compound D UNII-LV4PI5YV3S Adapalene Related Compound D (4,4''-dimethoxy-3,3''-di(adamant-1-yl)biphenyl) Adapalene Related Compound D (25 mg) (4,4'-dimethoxy-3,3'-di(adamant-1-yl)biphenyl) 1,1'-[4,4'-Bis(methoxy)-biphenyl-3,3'- diyl]bis(tricyclo[3.3.1.1(3,7)]decane) Adapalene Impurity 4(Adapalene Impurity D) 1,1'-(4,4'-Dimethoxy[1,1'-biphenyl]-3,3'-diyl)bis[tricyclo[3.3.1.13,7]decane Adapalene Impurity D 1,1'-(4,4'-Dimethoxy-[1,1'-biphenyl]-3,3'-diyl)bis(adamantane) (Adapalene Impurity) ADAP-IMC Adapalene Impurity D RC D) 1,1'-(4,4'-DiMethoxy[1,1'-biphenyl]-3,3'-diyl)bistricyclo[3.3.1.13,7]decane Adapalene Impurity 3 1,1'-[4,4'Bis(methoxy)biphenyl-3,3'-diyl]bis(tricyclo[3.3.1.13,7]decane) |
| Molecular Formula | C34H42O2 |
|---|---|
| Molecular Weight | 482.69600 |
| Exact Mass | 482.31800 |
| PSA | 18.46000 |
| LogP | 8.30640 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319 |
| Precautionary Statements | P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Phrases | 36/38 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |
|
~0%
932033-57-3 |
| Literature: Puig Serrano, Jordi Patent: US2009/131713 A1, 2009 ; Location in patent: Page/Page column 3; 5 ; |
|
~41%
932033-57-3 |
| Literature: Puig Serrano, Jordi Patent: US2009/131713 A1, 2009 ; Location in patent: Page/Page column 6 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |